Slide 2

Patient-Focused Innovation

Kashiv BioSciences is a fully-integrated biopharmaceutical company developing advanced-stage biosimilars and complex products addressing unmet patient needs worldwide.

Slide 2

Robust R&D Capabilities

With end-to-end platform capabilities for small and large molecules, we develop programs across a range of therapeutic areas and regulatory pathways.

Slide 2

Carefully Crafted Pipeline

Our pipeline reflects our unique capabilities, featuring advanced-stage biosimilars, complex generics, 505(b)(2), and mRNA therapies.

previous arrow
next arrow

Who We Are

We are a premier, fully integrated biopharmaceutical company built on patient-focused innovation to develop clinically differentiated products.

    Kashiv BioSciences is dedicated to developing medicines for unmet patient needs and responding to the global demand for increased access to biologic treatments.

    Learn More

~~ Our Achievement : USFDA APPROVED ~~

Developing Innovative and Effective Biopharmaceutical Products

Filgrastim Biosimilar (Releuko®)- USFDA Approved

Pegfilgrastim Biosimilar (Fylnetra®)- USFDA Approved

What we do?

Science & Innovation

Our research & development is highly focused on areas of unmet therapeutic needs and we have pipeline of differentiated products across various segments.

Explore Services

Kashiv BioSciences

We're among those who think that
BioScience has a Great Beauty.

World Class Quality & Accuracy
by Professional Experts